Discovery of the nonfunctional CYP2D6*31 allele in Spanish, Puerto Rican, and US Hispanic populations

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  2010-05-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00228-010-0831-4PMID 20473659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of CYP2D6 genetic polymorphisms on postoperative morphine consumption.

  2009cited by this paper
• The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction

  2009cited by this paper
• DNA Microarray Technology in the Clinical Environment: The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping

  2009cited by this paper
• The Genetic Legacy of Religious Diversity and Intolerance: Paternal Lineages of Christians, Jews, and Muslims in the Iberian Peninsula

  2008influential reference
• Evaluation of a [13C]‐Dextromethorphan Breath Test to Assess CYP2D6 Phenotype

  2008cited by this paper
• The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype

  2008cited by this paper
• Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

  2008cited by this paper
• CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure

  2007cited by this paper
• Ontogeny of Dextromethorphan O‐ and N‐demethylation in the First Year of Life

  2007cited by this paper
• AmpliChip CYP450 GeneChip®: A New Gene Chip That Allows Rapid and Accurate CYP2D6 Genotyping

  2006cited by this paper
• Functional analysis of CYP2D6.31 variant: Homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution

  2005cited by this paper
• Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

  2003cited by this paper
• Unique CYP2D6 activity distribution and genotype‐phenotype discordance in black Americans

  2002cited by this paper
• Pharmacokinetic Drug Interaction Potential of Risperidone With Cytochrome P450 Isozymes as Assessed by the Dextromethorphan, the Caffeine, and the Mephenytoin Test

  2001cited by this paper
• Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes.

  2001cited by this paper
• Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.

  1997influential reference

• Analysis of CYP2D6 Gene Variant Frequencies in Iranian Population

  2025cites this paper
• A Comparison of Molecular Techniques for Improving the Methodology in the Laboratory of Pharmacogenetics

  2024cites this paper
• Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy

  2022cites this paper
• Association of cytochrome P2D6 gene polymorphism with the susceptibility of Egyptian patients to systemic sclerosis disease

  2021cites this paper
• Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and European Society for Pharmacogenomics a

  2021cites this paper
• Pharmacogenomics in Latin American Populations

  2019cites this paper
• Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population

  2019cites this paper
• Farmacogenómica: la medicina personalizada

  2019cites this paper
• PharmVar GeneFocus: CYP2D6

  2019cites this paper
• Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark

  2018cites this paper
• 2-1-2016 Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP 2 D 6 Poor Metabolizers Diagnosed With Bipolar Disorder

  2018cites this paper
• Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder

  2016cites this paper
• Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

  2016cites this paper
• Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro

  2016cites this paper
• Assessment of 25 CYP2D6 alleles found in the Chinese population on propafenone metabolism in vitro.

  2016cites this paper
• Ethnicity and Response to Drug Therapy

  2016cites this paper
• CYP2D6 Haplotype Determination Using Long Range Allele-Specific Amplification: Resolution of a Complex Genotype and a Discordant Genotype Involving the CYP2D6*59 Allele.

  2015cites this paper
• Pharmacogenetics in Central American healthy volunteers: interethnic variability

  2015cites this paper
• Pharmacogenetics of healthy volunteers in Puerto Rico

  2015cites this paper
• Pharmacogenetics of drug-metabolizing enzymes in US Hispanics

  2015cites this paper
• CYP2D6 and pharmacogenomics: where does future research need to focus? Part 1: technical aspects.

  2014cites this paper
• Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics.

  2014cites this paper
• Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans.

  2014cites this paper
• Characterization of a complex CYP2D6 genotype that caused an AmpliChip CYP450 Test® no-call in the clinical setting

  2014cites this paper
• Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization.

  2014cites this paper
• Resolution of a clinical AmpliChip CYP450 Test™ no call: discovery and characterization of novel CYP2D6*1 haplotypes.

  2014cites this paper
• CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspects.

  2014cites this paper
• Pharmacogenetics in American Indian populations: analysis of CYP2D6, CYP3A4, CYP3A5, and CYP2C9 in the Confederated Salish and Kootenai Tribes

  2013cites this paper
• Complexities of CYP2D6 gene analysis and interpretation

  2013cites this paper
• Pharmacogenomics of CYP2D6: molecular genetics, interethnic differences and clinical importance.

  2012cites this paper
• Pharmacogenomics of CYP 2 D 6 : Molecular Genetics , Interethnic Differences and Clinical Importance

  2012cites this paper
• Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes

  2011cites this paper
• Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican Mestizos.

  2011cites this paper
• Detection and characterization of the CYP2D6*9x2 gene duplication in two Spanish populations: resolution of AmpliChip CYP450 test no-calls.

  2011cites this paper
• Genetic variants of the drug-metabolizing enzyme CYP2D6 in Puerto Rican psychiatry patients: a preliminary report and potential implications for breast cancer patients.

  2010cites this paper
• Results and challenges of Cytochrome P450 2D6 (CYP2D6) Results and challenges of Cytochrome P450 2D6 (CYP2D6) testing in an ethnically diverse South Florida population testing in an ethnically diverse South Florida population

  year unknowninfluential citation